CVKD
Price
$16.54
Change
+$1.12 (+7.26%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
29.71M
5 days until earnings call
LQDA
Price
$13.89
Change
+$0.06 (+0.43%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
1.18B
One day until earnings call
Ad is loading...

CVKD vs LQDA

Header iconCVKD vs LQDA Comparison
Open Charts CVKD vs LQDABanner chart's image
Cadrenal Therapeutics
Price$16.54
Change+$1.12 (+7.26%)
Volume$100
Capitalization29.71M
Liquidia
Price$13.89
Change+$0.06 (+0.43%)
Volume$30.46K
Capitalization1.18B
CVKD vs LQDA Comparison Chart
Loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVKD vs. LQDA commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVKD is a Buy and LQDA is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (CVKD: $15.42 vs. LQDA: $13.82)
Brand notoriety: CVKD and LQDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVKD: 92% vs. LQDA: 202%
Market capitalization -- CVKD: $29.71M vs. LQDA: $1.18B
CVKD [@Biotechnology] is valued at $29.71M. LQDA’s [@Biotechnology] market capitalization is $1.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVKD’s FA Score shows that 0 FA rating(s) are green whileLQDA’s FA Score has 1 green FA rating(s).

  • CVKD’s FA Score: 0 green, 5 red.
  • LQDA’s FA Score: 1 green, 4 red.
According to our system of comparison, LQDA is a better buy in the long-term than CVKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVKD’s TA Score shows that 5 TA indicator(s) are bullish while LQDA’s TA Score has 5 bullish TA indicator(s).

  • CVKD’s TA Score: 5 bullish, 5 bearish.
  • LQDA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LQDA is a better buy in the short-term than CVKD.

Price Growth

CVKD (@Biotechnology) experienced а -11.38% price change this week, while LQDA (@Biotechnology) price change was -7.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.64%. For the same industry, the average monthly price growth was -8.11%, and the average quarterly price growth was -7.39%.

Reported Earning Dates

CVKD is expected to report earnings on May 08, 2025.

LQDA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+0.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LQDA($1.18B) has a higher market cap than CVKD($29.7M). LQDA YTD gains are higher at: 17.517 vs. CVKD (6.418). CVKD has higher annual earnings (EBITDA): -7.61M vs. LQDA (-107.21M). LQDA has more cash in the bank: 204M vs. CVKD (4.36M). CVKD has less debt than LQDA: CVKD (2.23K) vs LQDA (2.69M). LQDA has higher revenues than CVKD: LQDA (15.6M) vs CVKD (0).
CVKDLQDACVKD / LQDA
Capitalization29.7M1.18B3%
EBITDA-7.61M-107.21M7%
Gain YTD6.41817.51737%
P/E RatioN/AN/A-
Revenue015.6M-
Total Cash4.36M204M2%
Total Debt2.23K2.69M0%
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
33
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVKDLQDA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 28 days ago
88%
Bullish Trend 7 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIIFX27.98N/A
N/A
Pioneer International Equity A
FRGSX107.31N/A
N/A
Franklin Growth C
EDIIX10.76N/A
N/A
Eaton Vance Global Income Builder I
MMUGX21.86N/A
N/A
MFS Utilities R1
HRIIX10.97N/A
N/A
Hood River International Opportunity Inv

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and GDTC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and GDTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-8.49%
GDTC - CVKD
29%
Poorly correlated
-7.75%
MNPR - CVKD
27%
Poorly correlated
-1.72%
AADI - CVKD
23%
Poorly correlated
-8.96%
LQDA - CVKD
22%
Poorly correlated
-6.75%
GOSS - CVKD
22%
Poorly correlated
-4.96%
More

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with ALNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
-6.75%
ALNY - LQDA
37%
Loosely correlated
-4.64%
AXON - LQDA
32%
Poorly correlated
-2.08%
AVXL - LQDA
30%
Poorly correlated
+3.69%
XERS - LQDA
29%
Poorly correlated
+8.25%
KURA - LQDA
29%
Poorly correlated
-3.85%
More